Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Richon

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2000
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylationV M Richon, T W Sandhoff, R A Rifkind, et al.
Gene|June 22, 1999
Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiationX Zhou, V M Richon, L Ngo, et al.
Progress in Clinical and Biological Research|January 1, 1989
Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELCP A Marks, J Michaeli, J Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1H Kiyokawa, V M Richon, G Venta-Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2004
Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1C-Y Gui, L Ngo, W S Xu, et al.
Nature Reviews. Cancer|March 21, 2002
Histone deacetylases and cancer: causes and therapiesP Marks, R A Rifkind, V M Richon, et al.
The Prostate|January 1, 1988
Heparin-binding growth factor isolated from human prostatic extractsJ H Mydlo, M A Bulbul, V M Richon, et al.
Anticancer Research|March 4, 2000
Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)L A Cohen, S Amin, P A Marks, et al.
Cancer Research|December 4, 2001
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cellsP N Munster, T Troso-Sandoval, N Rosen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2000
Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic RasX Zhou, V M Richon, A H Wang, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2000
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylationV M Richon, T W Sandhoff, R A Rifkind, et al.
Gene|June 22, 1999
Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiationX Zhou, V M Richon, L Ngo, et al.
Progress in Clinical and Biological Research|January 1, 1989
Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELCP A Marks, J Michaeli, J Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1H Kiyokawa, V M Richon, G Venta-Perez, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2004
Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1C-Y Gui, L Ngo, W S Xu, et al.
Nature Reviews. Cancer|March 21, 2002
Histone deacetylases and cancer: causes and therapiesP Marks, R A Rifkind, V M Richon, et al.
The Prostate|January 1, 1988
Heparin-binding growth factor isolated from human prostatic extractsJ H Mydlo, M A Bulbul, V M Richon, et al.
Anticancer Research|March 4, 2000
Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)L A Cohen, S Amin, P A Marks, et al.
Cancer Research|December 4, 2001
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cellsP N Munster, T Troso-Sandoval, N Rosen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2000
Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic RasX Zhou, V M Richon, A H Wang, et al.
Pageof 5